Literature DB >> 16956916

Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation.

Fredrik Holmqvist1, Martin Stridh, Johan E P Waktare, Leif Sörnmo, S Bertil Olsson, Carl J Meurling.   

Abstract

AIMS: The study set out to explore whether an index of atrial electrical electrophysiology can be used to predict atrial fibrillation (AF) relapse, and if the predictive properties differ as a result of arrhythmia duration. METHODS AND
RESULTS: The study comprised 175 consecutive patients with persistent AF (median duration 94 days, range 2 to 1044) referred for cardioversion. Twenty-nine patients had arrhythmia duration under 30 days (median 5 days, range 2-26). Atrial fibrillatory rate (AFR) was estimated using a frequency power spectrum analysis of QRST-cancelled ECG. At 1-month follow-up, 56% of the patients had relapsed to AF. The pre-cardioversion mean AFR of those patients was 399+/-52 fibrillations per minute (fpm) compared with 363+/-63 fpm among patients maintaining SR (P<0.0001). In patients with short AF duration, the difference was even more pronounced (424+/-52 vs. 345+/-65 fpm, P<0.01). In this group, a finding of an AFR above the mean value of the study population predicted AF relapse with high accuracy.
CONCLUSION: In patients undergoing cardioversion of persistent AF, AF relapse is predicted by a higher AFR. A stronger association is seen in patients with short arrhythmia duration, reflecting either rapid remodelling or pre-existing changes in those who relapse to AF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16956916     DOI: 10.1093/eurheartj/ehl098

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  11 in total

1.  The Telemetric and Holter ECG Warehouse (THEW): the first three years of development and research.

Authors:  Jean-Philippe Couderc
Journal:  J Electrocardiol       Date:  2012-09-28       Impact factor: 1.438

2.  Predictors of successful cardioversion with vernakalant in patients with recent-onset atrial fibrillation.

Authors:  Natalia Mochalina; Tord Juhlin; Bertil Öhlin; Jonas Carlson; Fredrik Holmqvist; Pyotr G Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-07-09       Impact factor: 1.468

3.  Association between atrial fibrillatory rate and heart rate variability in patients with atrial fibrillation and congestive heart failure.

Authors:  Valentina D A Corino; Iwona Cygankiewicz; Luca T Mainardi; Martin Stridh; Rafael Vasquez; Antonio Bayes de Luna; Fredrik Holmqvist; Wojciech Zareba; Pyotr G Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-11-22       Impact factor: 1.468

Review 4.  Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.

Authors:  Jeffrey J Goldberger; Rishi Arora; David Green; Philip Greenland; Daniel C Lee; Donald M Lloyd-Jones; Michael Markl; Jason Ng; Sanjiv J Shah
Journal:  Circulation       Date:  2015-07-28       Impact factor: 29.690

5.  A non-invasive method to predict electrical cardioversion outcome of persistent atrial fibrillation.

Authors:  Raúl Alcaraz; José Joaquín Rieta
Journal:  Med Biol Eng Comput       Date:  2008-04-24       Impact factor: 2.602

6.  Non-invasive atrial fibrillation organization follow-up under successive attempts of electrical cardioversion.

Authors:  Raúl Alcaraz; José Joaquín Rieta; Fernando Hornero
Journal:  Med Biol Eng Comput       Date:  2009-12       Impact factor: 2.602

7.  A genotype-dependent intermediate ECG phenotype in patients with persistent lone atrial fibrillation genotype ECG-phenotype correlation in atrial fibrillation.

Authors:  Daniela Husser; Martin Stridh; Leif Sörnmo; Dan M Roden; Dawood Darbar; Andreas Bollmann
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02

8.  Application of Wavelet Entropy to predict atrial fibrillation progression from the surface ECG.

Authors:  Raúl Alcaraz; José J Rieta
Journal:  Comput Math Methods Med       Date:  2012-09-26       Impact factor: 2.238

9.  Developing a New Computer-Aided Clinical Decision Support System for Prediction of Successful Postcardioversion Patients with Persistent Atrial Fibrillation.

Authors:  Mark Sterling; David T Huang; Behnaz Ghoraani
Journal:  Comput Math Methods Med       Date:  2015-05-18       Impact factor: 2.238

10.  Atrial fibrillation cycle length and atrial size in horses with and without recurrence of atrial fibrillation after electrical cardioversion.

Authors:  D De Clercq; A Decloedt; S U Sys; T Verheyen; N Van Der Vekens; G van Loon
Journal:  J Vet Intern Med       Date:  2014-02-24       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.